Correlation Between Rumble and Astellas Pharma

Can any of the company-specific risk be diversified away by investing in both Rumble and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rumble and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rumble Inc and Astellas Pharma, you can compare the effects of market volatilities on Rumble and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rumble with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rumble and Astellas Pharma.

Diversification Opportunities for Rumble and Astellas Pharma

-0.73

Correlation Coefficient

Rumble  Astellas Pharma

Pay attention - limited upside

The 3 months correlation between Rumble and Astellas is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Rumble Inc and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and Rumble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rumble Inc are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of Rumble i.e., Rumble and Astellas Pharma go up and down completely randomly.

Pair Corralation between Rumble and Astellas Pharma

Considering the 90-day investment horizon Rumble Inc is expected to generate 4.24 times more return on investment than Astellas Pharma. However, Rumble is 4.24 times more volatile than Astellas Pharma. It trades about 0.35 of its potential returns per unit of risk. Astellas Pharma is currently generating about -0.2 per unit of risk. If you would invest  561.00  in Rumble Inc on September 16, 2024 and sell it today you would earn a total of  269.00  from holding Rumble Inc or generate 47.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Rumble Inc  vs.  Astellas Pharma

Rumble Inc

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Rumble Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Rumble displayed solid returns over the last few months and may actually be approaching a breakup point.

Astellas Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Rumble and Astellas Pharma

The main advantage of trading using opposite Rumble and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rumble position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.

The idea behind Rumble Inc and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.